AceLink Therapeutics Pipeline
| Drug | Indication | Phase |
|---|
| AL01211 | Fabry disease; Type I Gaucher disease | Phase 2 |
| AL0804 | Neuronopathic Gaucher disease (Types II/III); GM1/GM2 Gangliosidosis; Genetic Parkinson's | Preclinical |
| AL1311 | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Preclinical |